Milton Menahem Yisrael

The Phoenix Advanced Investments Ltd. is a holding company which engages in financial and pension fields. It operates through the Provident Fund Management, Pension Fund Management, Advanced Investment Management, and Agent House. The Provident Fund Management segment includes study funds, personally managed provident funds and central compensation funds, it provides a medium and long-term savings route, the main purpose of which is the accumulation of savings, which can be withdrawn at retirement as a monthly allowance. The Pension Fund Management segment provides long-term savings instrument, intended to be paid from retirement age as a pension. The Advanced Investment Management segment engages in contracts for the distribution and distribution of international investment funds. The Agent House segment Includes brokerage services, marketing, and distribution of medium and long-term savings products as well as insurance products and financial products provided by the company. The company was founded on May 7, 1990 and is headquartered in Holon, Israel.

Vensica Medical Ltd. operates as a medical device company. It designs and develops ultrasound catheter for the treatment of bladder cancer. The firm creates a drug delivery platform to the urinary bladder using the VensiCare device, ultrasound cavitation safely and effectively delivers Botox into the bladder wall in a quick, painfree, needlefree procedure in an office setting. The company was founded by Avner Geva in 2013 and is headquartered in Misgav, Israel.

Renalsense Ltd. is a privately owned Israeli medical device company that specializes in real-time renal diagnostics. The company is based in Jerusalem, Israel. The company's first product, Clarity RMS, provides continuous and automatic monitoring of urine flow for early detection of acute kidney injury (AKI). Renalsense aims to improve critical care management in the ICU and peri-operative setting by providing additional real-time parameters and expanded diagnostic capabilities in their next-generation products. Renalsense was founded in 2009 by Avi Kleiman and Mor Grinstein, and Avi Kleiman has been the CEO since then.